# Dynport Vaccine Company LLC

Canonical: https://abierto.us/vendors/dynport-vaccine-company-llc-lxnegtydr755

- UEI: LXNEGTYDR755
- CAGE: 1GFE1
- Parent: General Dynamics Corp.
- Location: Frederick, MD
- Awards in window: 8 (10 transactions), $215,702 obligated, January 14, 2026 to September 3, 2026

## Awarding agencies

- National Institutes of Health: 5 awards, $209,616
- Defense Health Agency: 1 awards, $6,087
- Department of the Army: 2 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $219,136
- 541712 Professional, Scientific, and Technical Services: $6,087
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0
- 541711 Professional, Scientific, and Technical Services: -$9,520

## Competition

- Full and Open Competition: 8 awards

## Largest awards

- 75N93022F00001 (delivery order): $219,136, National Institutes of Health Niaid. Task Order 75N93022F00001 Base Award. https://www.usaspending.gov/award/CONT_AWD_75N93022F00001_7529_75N93022D00016_7529/
- 0002 (delivery order): $6,087, Army Med Res Acq Activity. Tafenoquine Clinical Trials. https://www.usaspending.gov/award/CONT_AWD_0002_9700_W81XWH15D0037_9700/
- W911QY13C0056 (definitive contract): $0, W6QK ACC-APG. Termination Settlement Proposal Deadline for FDA Licensure of a Bioscavenger Prophylaxis.. https://www.usaspending.gov/award/CONT_AWD_W911QY13C0056_9700_-NONE-_-NONE-/
- W911QY21C0093 (definitive contract): $0, W6QK ACC-APG. Stability Testing. https://www.usaspending.gov/award/CONT_AWD_W911QY21C0093_9700_-NONE-_-NONE-/
- 75N93022D00016: $0, National Institutes of Health Niaid. Eo 14398 - Early Phase Clinical Trial Units (Epctu). https://www.usaspending.gov/award/CONT_IDV_75N93022D00016_7529/
- 75N93023D00016: $0, National Institutes of Health Niaid. EO14398, Rfo, Inv, Non-Commercial Bot. https://www.usaspending.gov/award/CONT_IDV_75N93023D00016_7529/
- HHSN27200003 (delivery order): -$639, National Institutes of Health Niaid. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_HHSN27200003_7529_HHSN272201500005I_7529/
- 75N93020F00001 (delivery order): -$8,881, National Institutes of Health Niaid. 1500005I Dynport Vaccine Company. https://www.usaspending.gov/award/CONT_AWD_75N93020F00001_7529_HHSN272201500005I_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/dynport-vaccine-company-llc-lxnegtydr755.